Corticosteroids vs insulin doses adjustment

Reading File
Finding Sources
Searching PubMed

corticosteroid induced hyperglycemia insulin management

Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Searching the Web

corticosteroid induced hyperglycemia insulin dose adjustment guidelines 2024 2025

Reading Web Page

https://pmc.ncbi.nlm.nih.gov/articles/PMC8157052

Here is a comprehensive guide to insulin dose adjustment when patients are on corticosteroids, synthesized from Harrison's 22E, a practical PMC management guide, and clinical guidelines.

Corticosteroids and Insulin Dose Adjustment

Why Corticosteroids Raise Blood Glucose

Glucocorticoids cause hyperglycemia through four mechanisms (Harrison's Principles of Internal Medicine 22E, 2025):
  • Increased insulin resistance (peripheral glucose utilization falls)
  • Increased hepatic glucose production (gluconeogenesis)
  • Impaired insulin secretion (beta-cell dysfunction)
  • Lipolysis and proteolysis providing gluconeogenic substrate
The resulting hyperglycemia is:
  • Dose-dependent - more steroid = more hyperglycemia
  • Postprandial-predominant with intermediate-acting steroids (e.g., prednisone)
  • Around-the-clock with long-acting steroids (e.g., dexamethasone)
  • Usually reversible when steroids are tapered/stopped
If new-onset hyperglycemia persists on >5 mg prednisone-equivalent chronically, it is termed "steroid-induced diabetes."

Step 1 - Assess Baseline Status

BaselineTypical Fasting GlucoseApproach
No prior diabetes, mild hyperglycemiaNear normal FPGLifestyle + monitoring only, or oral agent (sulfonylurea)
Pre-existing T2DM on oralsFPG <11.1 mmol/L (<200 mg/dL)Oral agents (e.g., sulfonylurea) may suffice; increase dose
Pre-existing T2DM or any, FPG elevatedFPG >11.1 mmol/L (>200 mg/dL)Insulin required
Pre-existing insulin-treated T1DM or T2DMAnyInsulin dose increase required
Note: Oral agents such as SGLT-2 inhibitors should be stopped on admission (or up to a week before elective admission) due to DKA risk. Metformin should be held if renal function is at risk.

Step 2 - Match Insulin Strategy to Steroid Type

Once-daily morning prednisone / prednisolone (intermediate-acting)

This is the most common scenario. The glucose spike is postprandial and afternoon-dominant, peaking 4-8 hours after the morning dose.
Option A - NPH insulin (preferred for this pattern):
  • Add NPH in the morning with (or just after) the steroid dose
  • NPH's peak action at 4-8 hours matches the steroid-induced glucose peak
  • Initial dose based on prednisone dose:
Prednisone doseDexamethasone equivalentNPH / Basal insulin starting dose
10 mg/day2 mg/day0.1 IU/kg/day
20 mg/day4 mg/day0.2 IU/kg/day
30 mg/day6 mg/day0.3 IU/kg/day
≥40 mg/day≥8 mg/day0.4 IU/kg/day
  • Alternatively: start NPH at 10 units in the morning; up-titrate by 10-20% daily based on morning glucose
  • If patient is already on basal-bolus insulin: increase the AM basal or premixed insulin dose by 20%, then titrate by 10% increments
Option B - Increased rapid-acting insulin:
  • Give extra rapid-acting insulin with breakfast/lunch to blunt the post-steroid spike
  • This shifts the rapid:basal ratio above the usual 50:50
For patients already on basal insulin only: add NPH in the morning or increase existing basal by 20% and re-check.

Long-acting steroids (dexamethasone, methylprednisolone)

These cause continuous 24-hour hyperglycemia, not just postprandial.
  • Use twice-daily NPH (initial dose: 0.3 IU/kg BW/day divided) or
  • Use long/ultra-long-acting basal analog (glargine U100/U300 or degludec), initial dose 0.2 IU/kg/day
  • Reassess glucose 24 hours after steroid intake; up-titrate by 20% if BG >18 mmol/L (>320 mg/dL), or 10% if BG 12.1-18 mmol/L (220-320 mg/dL)

Short-acting steroids (hydrocortisone)

  • A rapid-acting insulin bolus at the time of hydrocortisone administration is often sufficient
  • Add a corrective rapid-acting dose 3-4 hours later if glucose remains elevated
  • The rapid:basal insulin ratio will exceed 50:50 temporarily

Step 3 - Insulin Titration Rule of Thumb

When the glucocorticoid dose is being changed (up or down):
Adjust insulin by half the percentage of the GC dose change.
Example: GC increased 50% → increase insulin dose by ~25% Example: GC tapered 40% → reduce insulin dose by ~20%

Step 4 - Stopping Steroids (Taper/Discontinuation)

  • Once steroids are stopped, reduce insulin by 50% immediately, then down-titrate further per glucose levels (hyperglycemia may take a few days to fully resolve)
  • Patients established on insulin before steroids were started: return to pre-steroid doses (or reduce by 50% if pre-admission dose not known)
  • Patients on oral agents before (who needed insulin for steroids): stop the insulin and resume oral therapy

Special Notes

  • Type 1 diabetes: More prone to hypoglycemia when doses are increased. Adjust more cautiously; consider endocrinology input.
  • In-hospital targets: Glucose 6-10 mmol/L (108-180 mg/dL), accepting 4-12 mmol/L (72-216 mg/dL) for most patients. Avoid tight control in the frail elderly, confused patients, or those with dementia.
  • Monitoring: Check blood glucose before meals and at bedtime. More frequent monitoring during steroid initiation, dose changes, or tapering.
  • Outpatient setting: If FPG is near normal, a sulfonylurea (e.g., glipizide) taken with breakfast may be adequate for once-daily morning prednisolone. Insulin is still preferred when FPG >200 mg/dL.

Quick Reference Summary

Steroid TypeGlucose PatternInsulin of ChoiceStarting Strategy
Prednisolone (once AM)Postprandial / afternoon peakNPH AM0.1 U/kg per 10 mg prednisone
DexamethasoneAll-day hyperglycemiaGlargine or twice-daily NPH0.2-0.3 U/kg/day
HydrocortisoneShort peak, resolves quicklyRapid-acting bolusWith each HC dose; correct at 3-4 h
High-dose pulse steroidsSevere all-day hyperglycemiaBasal-bolus regimen0.4 U/kg/day NPH equivalent; intensify rapidly
Sources: Harrison's Principles of Internal Medicine 22E, Practical Guide - PMC8157052, NHS Wales Steroid Hyperglycaemia Guidelines (2025)

Iv insuline infusion protocol

Finding Sources
Searching the Web

IV insulin infusion protocol critical care 2024 2025 titration algorithm

Finding Sources
Reading Web Page

https://pmc.ncbi.nlm.nih.gov/articles/PMC12261788

Finding Sources
Finding Sources
Reading File
Reading File
Here is a comprehensive, clinically practical IV insulin infusion protocol guide.

IV Insulin Infusion Protocol (Continuous Insulin Infusion - CII)

Indications

IV insulin infusion is preferred over subcutaneous insulin in the following settings:
  • Critical illness hyperglycemia (BG persistently ≥180 mg/dL in the ICU)
  • Diabetic ketoacidosis (DKA) and Hyperglycemic Hyperosmolar State (HHS)
  • Perioperative glucose management (cardiac surgery, major surgery, transplant)
  • TPN/TEN with unstable glucose requirements
  • NPO patients with rapidly changing insulin needs
  • Situations requiring precise, rapid titration

Glucose Targets by Society Guideline

SocietySettingTarget
ADAGeneralInitiate if BG >180 mg/dL; target 140-180 mg/dL
ADA (selected patients)ICU110-140 mg/dL may be appropriate
ACPICU140-200 mg/dL; recommends against intensive therapy
SCCM 2024ICUInitiate for persistent BG ≥180 mg/dL; target ≤180 mg/dL without hypoglycemia
Society of Thoracic SurgeonsOR/ICUContinuous infusion preferred; target <180 mg/dL intraoperatively; ≤110 mg/dL fasting/premeal
Endocrine SocietyGeneralPremeal <140 mg/dL; random <180 mg/dL
Practical consensus: Target BG 140-180 mg/dL for most ICU patients. A target of 110-140 mg/dL may be used in cardiac surgery ICUs with robust monitoring. Avoid tight control (<110 mg/dL) - the NICE-SUGAR trial showed increased mortality with intensive glycemic control.
Hypoglycemia definition: BG <70 mg/dL (action threshold); BG <40 mg/dL = severe hypoglycemia.

Preparation

ComponentDetail
Insulin typeRegular insulin only (not rapid-acting analogs)
Standard concentration50 units regular insulin in 50 mL 0.9% NaCl (1 unit/mL)
Infusion deviceSyringe pump or volumetric pump - always use a pump, never free-flow
IV lineDedicated line or dedicated lumen
Prime tubingFlush ~20-30 mL to saturate insulin adsorption to tubing before connecting to patient
Nutritional supportEnsure patient is receiving caloric source (D5W, TPN, enteral feeds) before starting insulin

Step 1 - Initiating the Infusion

Trigger criteria (ICU general hyperglycemia):
  • Two consecutive BG ≥150 mg/dL, or
  • Single BG ≥200 mg/dL
Discontinue all subcutaneous insulin once CII is started.

Initial Bolus (optional, situational)

Some protocols use a bolus before infusion start:
Bolus dose = BG (mg/dL) ÷ 100 (round to nearest unit) Example: BG = 280 → give 2-3 units IV bolus, then start infusion
Boluses are more commonly used in DKA protocols (0.1 units/kg IV bolus) than in general ICU protocols.

Starting Infusion Rate

A commonly used formula:
Initial rate (units/hr) = BG (mg/dL) ÷ 100 Example: BG = 240 mg/dL → start at 2.4 units/hr
Alternatively (weight-based starting points):
  • Insulin-sensitive: 0.02-0.05 units/kg/hr
  • Usual ICU patient: 0.05-0.1 units/kg/hr
  • Insulin-resistant: 0.1-0.2 units/kg/hr

Step 2 - Titration Algorithm (Nurse-Driven, Hourly)

The widely-used multi-algorithm approach escalates to higher infusion rates if glucose remains above target, and de-escalates if trending down or hypoglycemia occurs.

Standard Algorithm Table (Nurse-Led ICU Protocol)

Infusion rate = mL/hr (= units/hr at 1 unit/mL concentration)
BG (mg/dL)Algorithm 0Algorithm 1Algorithm 2Algorithm 3Algorithm 4
110-1490-0.50.511.52
150-1790.51234
180-20912345
210-2391.53456
240-26924567
270-2992.55678
300-32936789
330-359467911
>36058121416

Algorithm Movement Rules

ConditionAction
Two consecutive BG >target rangeMove UP one algorithm
BG drops below target or near hypoglycemiaMove DOWN one algorithm
BG <70 mg/dL (hypoglycemia)Stop infusion; treat hypoglycemia
BG >300 mg/dL (unresponsive)Notify physician; consider moving up

Titration Rule of Thumb (Simpler Approach - Portland Protocol style)

Rate (units/hr) = [BG - 60] × multiplier
  • Start with multiplier = 0.02
  • After two successive BG >130: increase multiplier
  • If BG <100: decrease multiplier
  • If BG <60: set multiplier to zero

Step 3 - Monitoring Frequency

PhaseBG Monitoring Frequency
First 8 hours of infusion, or after any algorithm changeEvery 1 hour
BG stable within target for 8 hoursEvery 2 hours
BG stable in target for extended periodMay extend to every 4 hours
Nutritional change (start/stop TPN, feeds)Every 30 minutes × 4 checks
Renal replacement therapy start/changeEvery 30 minutes × 4 checks
BG out of range againReturn to every 1 hour
Monitoring site: Use bedside glucometer for routine checks. If SBP <80 mmHg or poor perfusion, use arterial blood glucose from a heparinized arterial line (peripheral glucometry is unreliable in shock).

Step 4 - Hypoglycemia Management

BG LevelAction
<70 mg/dLStop insulin infusion immediately + give 25 mL of 25% dextrose IV (= 6.25 g glucose)
Still <70 after 30 minRepeat 25 mL D25W; notify physician
BG 70-110 mg/dLStop infusion; recheck every 1 hour
BG >110 mg/dL after hypoglycemiaStop infusion; recheck every 2 hours; restart at lower algorithm when BG ≥150
Unresponsive hypoglycemia (no resolution in 20 min after dextrose)Urgent physician notification
Alternative for mild hypoglycemia in alert patient: 15-20 g oral glucose (juice/glucose tabs).

Step 5 - Special Situations

DKA Protocol (differs from general CII)

  • Bolus: 0.1 units/kg IV before starting infusion
  • Infusion: 0.1 units/kg/hr
  • When BG reaches 250 mg/dL: reduce to 0.05 units/kg/hr and add dextrose to IV fluids (D5 or D10 in 0.45% NaCl) to maintain BG 150-200 mg/dL until anion gap closes and patient can eat
  • Do not stop insulin prematurely - continue until ketosis resolves

Perioperative (cardiac/major surgery)

  • Target: <180 mg/dL intraoperatively
  • Preferred over SC insulin for all major procedures
  • Society of Thoracic Surgeons recommends CII as preferred method in cardiac surgery

TPN patients

  • After determining total daily insulin requirement via separate insulin infusion, a portion may be added directly to the TPN bag for nutritional coverage
  • Continue a separate infusion for fine-tuning and correction

Step 6 - Transitioning Off IV Insulin to Subcutaneous

Do not abruptly stop CII when switching to SC insulin - insulin has minimal subcutaneous depot when transitioning from IV.
Transition protocol:
  1. Calculate the total insulin used in the last 6-8 hours × 4 (or last 24-hour IV insulin total)
  2. Give 80% of total daily requirement as SC insulin:
    • 50% as basal (glargine or detemir once or twice daily)
    • 50% as prandial (rapid-acting with each meal, split equally)
  3. Administer the first SC dose 1-2 hours before stopping the infusion (to allow SC depot to build)
  4. Continue BG monitoring every 1-2 hours for the first 4-6 hours after transition

Notify the Physician When:

  • BG change >100 mg/dL between two consecutive readings
  • BG ≥300 mg/dL
  • Hypoglycemia not responding to dextrose within 20 minutes
  • Algorithm 4 is insufficient (consult endocrinology)
  • Patient develops clinical signs of hypoglycemia at any BG level

Quick Reference Card

StepAction
Preparation50U regular insulin in 50mL NS (1U/mL); prime tubing; confirm caloric source
StartBG ≥200 (single) or ≥150 (×2); initial rate = BG÷100 units/hr
TargetBG 140-180 mg/dL (most ICU patients)
TitrateHourly checks; escalate/de-escalate algorithm per BG trend
HypoglycemiaStop infusion; D25W 25 mL IV if BG <70
Transition to SC24hr IV total → 80% as basal-bolus SC; give first SC dose 1-2h before stopping CII
Sources: Sabiston Textbook of Surgery; Current Surgical Therapy 14e; SCCM 2024 Glycemic Guidelines - VUMC; Nurse-Led Insulin Protocol PMC12261788
This is a shared conversation. Sign in to Orris to start your own chat.